The National Medicines Regulatory Authority in Côte d’Ivoire, l’Autorité Ivorienne de Régulation Pharmaceutique (AIRP), in conjunction with the Marketing Authorization Holder, Medisource Laboratories, has decided to recall a batch of Finifat 500mg chewable tablets.
Usage
Finifat consists of vitamin C as the active ingredient and is indicated for the management of passenger fatigue in adults and adolescent children. It comes in a box containing 25 blisters, with each blister holding 4 tablets.
READ ALSO: Pfizer’s Aldactone unavailable in Senegal due to missing excipient – African Pharmaceutical Review
Reason for Recall
The voluntary recall, initiated by Medisource, was due to a reported change in the tablets from a solid to a pasty form, compromising the quality of the product.
The affected product holds batch number 230602, with an expiry date of May 2025, and was manufactured in China by Liaoning Huarui Pharmaceutical Company.
A total of 33,450 boxes from this batch were distributed in Côte d’Ivoire.
Advice from l’AIRP
In a written communication, l’AIRP has advised all healthcare professionals to refrain from selling and/or promoting the affected batches and to return the product to the wholesale distributors for further action.
Additionally, the Authority has urged all stakeholders to report any side or adverse effects experienced as a result of using the product.
Did you find this informative? Subscribe for more.
